World Cord Blood Congress Co-Located With Annual Stem Cells Conference, 20-21 September 2012, Boston

Date: Jun-25-2012Public and private cord blood banks are facing a standstill. Costs to store cord blood and use in transplants remain extremely high. Lack of funding prevents cord blood from being researched and used to treat a number of indications. It is critical that we sustain this industry to continuously provide access to novel regenerative therapies.

The event is designed to help regional and international cord blood banks, biotechs, and academics learn how to get the most out of banking business strategies, cord blood therapeutic uses, and improved transplant opportunities. Furthermore, the event is co-located with our 4th Annual Stem Cells USA event, allowing even more networking opportunities! At this congress, you will learn:
How to raise and sustain funding through phase I, II, and III trials
How to source the newest and most exciting cord blood technology
How to comply with new FDA regulations around cord blood banking and therapy
How to find cost-effective strategies to improve access to cord blood for patients

Attend the World Cord Blood Congress to learn strategies to maintain a competitive edge in this rapidly expanding market.

To register or learn more visit http://www.terrapinn.com/cordblood.

CONTACT:

Caroline Hornby, Marketing Manager

Terrapinn

caroline.hornby@terrapinn.com

+1 646 619 1792

Courtesy: Medical News Today Note: Any medical information available in this news section is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.